Condensed Matter

   

New Nano-Molecule Kurumi and Raman Spectroscopy Using ab Initio, Hartree-Fock Method

Authors: Ricardo Gobato

btained in the methods Restrict Hartree-Fock of thfirst principles (ab initio), on the set of basis used indicate that the simulated molecule C 13 H 20 BeLi 2 SeSi/C 13 H 19 BeLi2SeSi features the structure polar-apolar-polar predominant. The set of basis used that have are correlation consistent polarized Triple-zeta (CC-pVTZ) and Pople’s basis sets six gaussian functions in the shell, three double zeta Gaussian functions, Slater type orbitals with polarization function (6-311G** (3df, 3pd)). In the CC-pVTZ base set, the charge density in relation to 6-311G** (3df, 3pd) is 50% lower. The length of the molecule C13H 20BeLi2SeSi is of 15.799Å. The Raman spectrum was calculated indicating the characteristic of the nano-molecule and their frequency (cm-1) were obtained in the set of bases used. The highest for Raman scattering activities peaks are in the frequency 3,348cm-1 with 7.107609729 Å4/amu and 2,163 cm-1 with 8.902805583 Å4/amu, for CC-pVTZ and 6-311G** (3df, 3pd), respectively. As the bio-inorganic molecule C13H20BeLi2SeSi is the basis for a new creation of a biomembrane, later calculations that challenge the current concepts of biomembrane shouldadvance to such a purpose. The new nano-molecule Kurumi is well characterize computationally. As its scientific name 3-lithio-3-(6-{3-selena-8-beryllatricyclo [3.2.1.0²,⁴] oct-6-en-2-yl} hexyl) -1-sila-2-lithacyclopropane

Comments: 6 Pages. Ricardo Gobato. New Nano-Molecule Kurumi and Raman Spectroscopy using ab initio, Hartree-Fock Method. Am J Biomed Sci & Res. 2019 - 2(4). AJBSR.MS.ID.000594. DOI: 10.34297/AJBSR.2019.02.000594

Download: PDF

Submission history

[v1] 2019-09-05 13:33:51

Unique-IP document downloads: 2 times

Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.

Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.

comments powered by Disqus